Blue Horseshoe Stocks: More New Highs on YGYI

Youngevity International Inc. YGYI

We’re coming right back to YGYI for the second straight morning, after the stock once again pushed to new 7-year highs on some of the biggest volume the stock has ever seen.

We slated this play for observation twelve days ago, and its performance across that span has been rather impressive. Our observed low on YGYI of 6.00 has quickly given way to the stock’s new high of 16.20, which represents a gain of 170% in a time frame of less than two weeks.

The stock closed very near to its high of day, and the record volume continues, so with that kind of momentum, we will undoubtedly continue to track its movements as it continues to pierce its way into blue skies.


Fresh Options Ideas

Morgan Stanley MS – In the case of Morgan Stanley, we’re going to come in with an options idea on the heels of the company’s Q3 earnings report. Our target contracts are going to be the MS Weekly $43.50 & $44 Calls.

Ferrari N.V. RACE – Ferrari is simply looking like a technically-sound bottom play at the moment, so we are going to signal some longer term calls here to coincide with a possible upcoming rebound. We’ll radar the RACE 10/26 $120-124 Calls here.


Extended Watchlist: 
SLS, LCI, SEND, CVE, KOOL, NSPR, FLKS

Blue Horseshoe Stocks: DRI Review & More

Darden Restaurants, Inc. DRI

On occasion, we’ll see an opportunity for a longer term move in a stock, and instead of signaling weekly options, we’ll select a later expiration date. This is what occurred with DRI, when we signaled the DRI 07/20 $100-115 Calls back on the 22nd of last month.

After roughly three weeks, DRI has done little else other than continue to climb, and it has provided some really great chances thus far in these contracts that are set to expire this Friday.

Here are the total gains that have been made possible by this idea to date:

$100 Calls – Range: 3.00-12.30 – Max Gain: 310%
$105 Calls – Range: .90-7.30 – Max Gain: 711%
$110 Calls – Range: .30-2.50 – Max Gain: 733%
$115 Calls – Range: .05-.55 – Max Gain: 1000%


Biocept, Inc. BIOC

We also want to track back to our tag of BIOC from Friday. The stock had been showing the beginnings of some bottom bounce activity earlier in the week, and our hunch that further gains were possible turned out to be correct.

BIOC traded in a daily range from 7.06 on up to a high of 12.15, which represented an intraday pop of 72% on Friday.


Extended Watchlist:
VLRX, RGSE, ATIS, ARNC, PULM, KOOL, SNES

Blue Horseshoe Stocks: TSLA Recap & More

Tesla, Inc. TSLA – Options Idea
-
TSLA stock was running hard after KeyBanc analysts predicted a 50% rise in Model 3 deliveries, and we entered the mix yesterday morning with a set of options ideas to take advantage of the situation. We certainly hope that our words didn’t fall upon deaf ears, because of the five contracts in the range we slated for potential quick strike trades, all five produced single-session gains of over 100%

Our designated targets were the TSLA Weekly 337.50-347.50 Calls and we were very impressed with the total potential gains made available by all of those contracts:

$337.50 Calls – Range: 8.00-19.00 – Max Gain: 138%
$340 Calls – Range: 6.76-17.10 – Max Gain: 153%
$342.50 Calls – Range: 5.75-15.16 – Max Gain: 164%
$345 Calls – Range: 4.97-13.50 – Max Gain: 172%
$347.50 Calls – Range: 4.20-11.90 – Max Gain: 183%

From what we’ve seen thus far, we have reason to believe that we may see some further opportunities in these ideas before the week is out, so we’ll allow them to keep their slots on our radar screens for the time being.


H&R Block, Inc. HRB – Fresh Idea

As a fresh options trading idea this morning, we want to bring attention to HRB, which despite turning in a beat on earnings yesterday in the post market, is taking a beating here in early trading.

Combined with the fact that the stock was already looking toppy and about to breach into heavily overbought territory, we’re ready to look at a range of puts, to take advantage of what may be a significant course correction to the low side. We’ll be tracking the HRB Weekly $26-24 Puts.


Extended Watchlist:
VTGN, DARE, SYK, OGEN, ESRX, PVTL, KFY, KOOL

Blue Horseshoe Stocks: CANN Recap & More

General Cannabis Corp. CANN

To kick off this week, we sent out a reminder going over the extensive list of cannabis plays we published on April 4th in anticipation of Friday’s 04/20 Holiday celebrations and connected stock activity.

We expect a rising tide of interest and activity in the cannabis space for the remainder of this week and beyond, during what is one of the busiest times of year for marijuana-related businesses/stocks.

We are already impressed with the move made by CANN since our initial alert and through to this week. On the 4th, following our report, CANN established its base at 2.25 and hasn’t looked back. Yesterday the stock hit 5.75, marking a two week bull run of 156% As we said, we expect to see more moves like this from the myriad cannabis plays we track on a regular basis. (Non-Exhaustive List Here)


vTv Therapeutics, Inc. VTVT

We also want to make note of VTVT this morning after noticing a number of attractive features on the chart. Pre-existing shareholders of VTVT are certainly not happy with the events of the past few months, but as opportunistic short-term traders, it has almost everything we look for a regular basis.

In addition to being monstrously oversold, the stock has seen a rise in average volume over the past week, after a massive gap-down which you can plainly view on the snapshot below. What makes the scenario so interesting, is that the company will need to reattain and hold the 1.00/share or risk involuntary delisting from the NASDAQ. With all these factors playing in, we’ll definitely want to put this one on extended watch in the event it attempts to fill even a portion of that gap.


Extended Watchlist:
NFLX, GS, UNH CNIT, CNET, VHC, RKDA, GWPH, KOOL

Blue Horseshoe Stocks: KOOL, TIF Recaps & More

Endocyte, Inc. ECYT

We initially took notice of ECYT on Monday morning just as the company announced it had completed a worldwide license for its prostate cancer treatment now moving into Phase-3 development.

The stock made a solid 130% rip from 1.63 to 3.75 that morning, but it was only just getting started. Yesterday morning the stock ran hard once again, reaching its peak at a new annual high of 6.55. That puts the total on our two-day observed increased of 302% while volume over the same period has been literally hundreds of times greater than the monthly average prior to Monday’s bombshell PR.


Tiffany & Co. TIF – Options Update

As we were just mentioning yesterday morning, we’ve been tracking the TIF 10/20 $92-93 Calls since the morning of September 28th. TIF stock has maintained its gradual ascent since that time, and with that, we’ve seen the potential gains made off of our ideas grow along with it.

The following ranges represent the lows from the 28th to the highs achieved during yesterday’s session:

$92 Calls – Range: 1.00-2.20 – Max Gain: 120%
$92.50 Calls – Range: .85-2.19  – Max Gain: 158%.
$93 Calls – Range: .83-2.15 – Max Gain: 159%


Cesca Therapeutics Inc. KOOL

After including KOOL in yesterday morning’s watchlist, we watched as the stock made a very nice intraday run on the chart with the help of some positive news.

The U.S. Patent and Trademark Office issued a Notice of Allowance on the company’s patent application for its proprietary method for separating target cells from blood, marrow, and other sources.

That prompted a solid boost from 3.96 to 6.44 on the day, marking an intraday push of 63% which was accompanied by the trading of 223X more shares than the monthly average!


Extended Watchlist:
CATB, RGSE, CAPR, ATNM, VKTX, MNKD, BIOP,  HTBX